LCN2 and myeloid sarcoma: In progressive MS, LCN2 plays a critical role in regulating CNS inflammation, inducing neuronal cell death, modulating dendritic spine formation, and controlling iron deposition and cellular transfer, thereby participating in both demyelination and neurodegeneration.